HERVolution Appoints Dr. Tine Gaziel as CMO to Advance Dark Genome-Targeting Immune Therapy into the Clinic
Hand-out
Press Releases
HERVOLUTION Therapeutics  
April 28, 2025

HERVolution Appoints Dr. Tine Gaziel as CMO to Advance Dark Genome-Targeting Immune Therapy into the Clinic

As an experienced and thoughtful medical executive, Dr. Gaziel directed key clinical development and research at Eli Lilly, Y-mAbs Therapeutics, and Genmab

avatar profile Olean Times Herald

Olean Times Herald


Local & Social